This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.


Ajinomoto Bio-Pharma Services


Ajinomoto Bio-Pharma Services is an established premier US-based provider for high containment ADC bioconjugation, offering process development, analytical development, formulation, clinical and commercial manufacturing and fill finish services, along with all supporting release and stability testing.

In addition, Ajinomoto Bio-Pharma Services is able to offer significant advantages for the next generation of ADCs through AJICAP™, an innovative direct chemical site-selective conjugation method for intact native antibodies. Our advanced method allows for high productivity, short conjugation reaction times and ease of manufacture.